Fidelity Small Cap Growth Fund Q4 2025 Commentary [Seeking Alpha]
Cogent Biosciences, Inc. (COGT)
Last cogent biosciences, inc. earnings: 11/8 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.cogint.com/investor-relations
Company Research
Source: Seeking Alpha
The fund's biggest individual relative contributor was an overweight in Cogent Biosciences, which gained 147% the past quarter. As 2026 begins, the global and U.S. business cycles remain constructive, with monetary and fiscal easing in the U.S. likely to continue. While we are cognizant of macroeconomic and geopolitical conditions, we continue to build the portfolio from the bottom up, company by company. Donny DBM/iStock via Getty Images Performance Review The fund's Retail Class shares gained 3.16% for the three months, outperforming the 1.22% advance of the Russell 2000® Growth Index. We'll note that longer-term performance comparisons largely favor the fund. During This article was written by Quick Insights Security selection in industrials and information technology, along with an overweight in health care, were key contributors to FCPGX's outperformance versus the Russell 2000 Growth Index. FCPGX is overweight health care, industrials, and consumer discretio
Show less
Read more
Impact Snapshot
Event Time:
COGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COGT alerts
High impacting Cogent Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
COGT
News
- Cogent Biosciences (COGT) had its "outperform" rating reaffirmed by Wedbush. They now have a $55.00 price target on the stock.MarketBeat
- Cogent Biosciences (COGT) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.MarketBeat
- Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) [Yahoo! Finance]Yahoo! Finance
- Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)GlobeNewswire
- Is Cogent Biosciences (COGT) One of the Best Multibagger Stocks to Buy According to Billionaires? [Yahoo! Finance]Yahoo! Finance
COGT
Sec Filings
- 2/17/26 - Form SCHEDULE
- 2/17/26 - Form S-8
- 2/17/26 - Form SCHEDULE
- COGT's page on the SEC website